Han Ma, M.D., Ph.D., joined BeOne in 2021 and serves as Chief Safety Officer and Senior Vice President, Global Patient Safety. Previously, she served as Vice President, Global Head of Safety Science and Epidemiology. Dr. Ma has nearly two decades of experience in the biopharmaceutical industry, spanning pre- and post-market clinical safety and risk management with a significant focus in oncology. Dr. Ma’s broad experience across the product lifecycle bridges clinical development with safety in support of making innovative medicines available to patients globally.
Prior to joining BeOne, she spent 20 years at Roche/Genentech in leadership roles with increasing responsibility within clinical development, discovery and translational research and patient safety. Notably, while at Roche, she served as Global Group Medical Director responsible for building and leading a safety sciences team in Shanghai supporting the entire Roche product portfolio in China. Prior to that, she served as the lead for the company’s global molecular virology and pharmacology group within the infectious diseases therapeutic area. Prior to joining the biopharma industry, she was a clinical oncologist for six years working directly with patients.
Dr. Ma earned an M.D. from Shanghai Medical College of Fudan University and a Ph.D. in molecular pathobiology from the University of Southern California.